- Corporate Officers - W
- Wolff Henry Ward
Insider Trading History of Wolff Henry Ward
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Wolff Henry Ward since 2006.
The trader's CIK number is 1302390.
At the time of the last reporting, Wolff Henry Ward was the CFO & SVP, Finance of Portola Pharmaceuticals Inc. (stock ticker symbol PTLA).
Also see all insider trading activities at Portola Pharmaceuticals Inc.
Note that in the past
Wolff Henry Ward also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Portola Pharmaceuticals Inc (PTLA) by Wolff Henry Ward
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | PTLA | 0 | $0 | 0 | $0 | 7,000 | $80,604 |
| 2017 | PTLA | 0 | $0 | 12,000 | $568,296 | 24,000 | $127,200 |
Yearly summary of insider trading at Sangamo Therapeutics, Inc (SGMO) by Wolff Henry Ward
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | SGMO | 0 | $0 | 104,000 | $1,512,228 | 90,000 | $526,899 |
| 2014 | SGMO | 0 | $0 | 106,000 | $1,673,208 | 127,500 | $560,775 |
| 2013 | SGMO | 0 | $0 | 90,000 | $941,020 | 70,000 | $241,500 |
| 2010 | SGMO | 9,000 | $27,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Abgenix Inc (ABGX) by Wolff Henry Ward
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2006 | ABGX | 0 | $0 | 0 | $0 | 22,500 | $223,762 |
Insider trading activities at 3 companies by Wolff Henry Ward:
1. Portola Pharmaceuticals Inc (PTLA)
2. Sangamo Therapeutics, Inc (SGMO)
3. Abgenix Inc (ABGX)
Table 1. Insider trading of Portola Pharmaceuticals Inc (PTLA) by Wolff Henry Ward
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-06-03 | PTLA | Option Ex | 2,000 | 27.55 | 55,104 |
| 2019-03-12 | PTLA | Option Ex | 5,000 | 5.10 | 25,500 |
| 2017-12-15 | PTLA | Sale | 12,000 | 47.36 | 568,296 |
| 2017-10-05 | PTLA | Option Ex | 12,000 | 5.30 | 63,600 |
| 2017-10-05 | PTLA | Option Ex | 12,000 | 5.30 | 63,600 |
Table 2. Insider trading of Sangamo Therapeutics, Inc (SGMO) by Wolff Henry Ward
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-07-10 | SGMO | Option Ex | 6,102 | 3.45 | 21,051 |
| 2015-07-13 | SGMO | Sale | 5,898 | 10.00 | 58,980 |
| 2015-07-13 | SGMO | Option Ex | 3,898 | 3.45 | 13,448 |
| 2015-07-10 | SGMO | Sale | 6,102 | 10.00 | 61,020 |
| 2015-06-10 | SGMO | Option Ex | 10,000 | 3.45 | 34,500 |
| 2015-06-10 | SGMO | Sale | 12,000 | 12.21 | 146,556 |
| 2015-05-11 | SGMO | Option Ex | 10,000 | 3.45 | 34,500 |
| 2015-05-11 | SGMO | Sale | 12,000 | 13.25 | 158,952 |
| 2015-04-10 | SGMO | Option Ex | 10,000 | 3.45 | 34,500 |
| 2015-04-10 | SGMO | Sale | 12,000 | 15.37 | 184,380 |
| 2015-03-19 | SGMO | Sale | 10,000 | 18.00 | 180,000 |
| 2015-03-19 | SGMO | Option Ex | 10,000 | 14.27 | 142,700 |
| 2015-03-10 | SGMO | Option Ex | 10,000 | 3.45 | 34,500 |
| 2015-03-10 | SGMO | Sale | 12,000 | 16.68 | 200,196 |
| 2015-03-04 | SGMO | Option Ex | 10,000 | 14.27 | 142,700 |
| 2015-03-04 | SGMO | Sale | 10,000 | 18.00 | 180,000 |
| 2015-02-10 | SGMO | Option Ex | 10,000 | 3.45 | 34,500 |
| 2015-02-10 | SGMO | Sale | 12,000 | 12.64 | 151,692 |
| 2015-01-12 | SGMO | Sale | 12,000 | 15.87 | 190,452 |
| 2015-01-12 | SGMO | Option Ex | 10,000 | 3.45 | 34,500 |
| 2014-12-11 | SGMO | Option Ex | 37,500 | .00 | 0 |
| 2014-11-10 | SGMO | Sale | 2,000 | 11.37 | 22,748 |
| 2014-10-10 | SGMO | Sale | 2,000 | 10.10 | 20,200 |
| 2014-09-10 | SGMO | Sale | 2,000 | 12.31 | 24,620 |
| 2014-08-11 | SGMO | Option Ex | 8,000 | 7.28 | 58,240 |
| 2014-08-11 | SGMO | Sale | 10,000 | 14.16 | 141,590 |
| 2014-07-10 | SGMO | Option Ex | 13,000 | 7.50 | 97,565 |
| 2014-07-10 | SGMO | Sale | 15,000 | 13.23 | 198,435 |
| 2014-06-10 | SGMO | Option Ex | 13,000 | 7.73 | 100,490 |
| 2014-06-10 | SGMO | Sale | 15,000 | 15.62 | 234,360 |
| 2014-05-12 | SGMO | Option Ex | 13,000 | 7.73 | 100,490 |
| 2014-05-12 | SGMO | Sale | 15,000 | 12.85 | 192,735 |
| 2014-04-10 | SGMO | Option Ex | 13,000 | 7.73 | 100,490 |
| 2014-04-10 | SGMO | Sale | 15,000 | 15.73 | 235,920 |
| 2014-03-10 | SGMO | Option Ex | 10,000 | 3.45 | 34,500 |
| 2014-03-10 | SGMO | Sale | 10,000 | 22.31 | 223,070 |
| 2014-02-10 | SGMO | Option Ex | 10,000 | 3.45 | 34,500 |
| 2014-02-10 | SGMO | Sale | 10,000 | 19.26 | 192,640 |
| 2014-01-10 | SGMO | Option Ex | 10,000 | 3.45 | 34,500 |
| 2014-01-10 | SGMO | Sale | 10,000 | 18.69 | 186,890 |
| 2013-12-10 | SGMO | Option Ex | 10,000 | 3.45 | 34,500 |
| 2013-12-10 | SGMO | Sale | 10,000 | 11.97 | 119,670 |
| 2013-11-13 | SGMO | Option Ex | 10,000 | 3.45 | 34,500 |
| 2013-11-13 | SGMO | Sale | 10,000 | 10.00 | 100,000 |
| 2013-10-10 | SGMO | Option Ex | 10,000 | 3.45 | 34,500 |
| 2013-10-10 | SGMO | Sale | 10,000 | 11.28 | 112,760 |
| 2013-09-10 | SGMO | Option Ex | 10,000 | 3.45 | 34,500 |
| 2013-09-10 | SGMO | Sale | 10,000 | 10.86 | 108,590 |
| 2013-08-13 | SGMO | Option Ex | 10,000 | 3.45 | 34,500 |
| 2013-08-13 | SGMO | Sale | 10,000 | 10.00 | 100,000 |
| 2013-07-17 | SGMO | Option Ex | 10,000 | 3.45 | 34,500 |
| 2013-07-17 | SGMO | Sale | 10,000 | 10.00 | 100,000 |
| 2013-04-10 | SGMO | Sale | 10,000 | 10.00 | 100,000 |
| 2013-02-28 | SGMO | Option Ex | 10,000 | 3.45 | 34,500 |
| 2013-02-28 | SGMO | Sale | 10,000 | 10.00 | 100,000 |
| 2013-01-23 | SGMO | Sale | 10,000 | 10.00 | 100,000 |
| 2010-08-30 | SGMO | Buy | 9,000 | 3.00 | 27,000 |
Table 3. Insider trading of Abgenix Inc (ABGX) by Wolff Henry Ward
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2006-03-24 | ABGX | Option Ex | 22,500 | 9.95 | 223,762 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Wolff Henry Ward
(CFO & SVP, Finance of Portola Pharmaceuticals Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.